Metware Biotechnology Inc. (MetwareBio) is dedicated to developing and applying innovative multi-omics technologies for life science and health research. By leveraging state-of-the-art mass spectrometry platforms, proprietary analytical workflows, and curated in-house databases, MetwareBio provides integrated multi-omics solutions for academic research, clinical studies, and biotechnology and pharmaceutical R&D.

MetwareBio's technical capabilities have supported over 1,000 publications in leading international peer-reviewed journals, including Cell, Nature Genetics, PNAS, Nature Communications, National Science Review, and many others. By partnering with MetwareBio, researchers gain access to comprehensive multi-omics expertise, robust analytical platforms, and dedicated technical support to accelerate scientific discovery and translational research.